CARA logo

CARA
Cara Therapeutics Inc

24,181
Mkt Cap
$42.5M
Volume
1,247.00
52W High
$43.65
52W Low
$3.74
PE Ratio
-0.46
CARA Fundamentals
Price
$4.52
Prev Close
$4.53
Open
$4.55
50D MA
$10.31
Beta
-0.13
Avg. Volume
150,398.63
EPS (Annual)
-$46.60
P/B
1.52
Rev/Employee
$713,700.00
Loading...
Loading...
News
all
press releases
Cara Therapeutics Stock Jumps 10% After Announcing 1-for-3 Reverse Stock Split: Retail Sentiment Soars
On Tuesday evening, every three issued and outstanding shares of CARA’s common stock will automatically be combined into one, effectively reducing the number of issued and outstanding shares of the company's common stock from about 4.6 million to 1.5 million.
Stocktwits·8mo ago
News Placeholder
More News
News Placeholder
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of...
PR Newswire·10mo ago
News Placeholder
CARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cara Therapeutics, Inc. - CARA
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of Cara Therapeutics, Inc. (NasdaqCM: CARA) and...
Business Wire·10mo ago
News Placeholder
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ML, PWOD, NURO, CARA on Behalf of Shareholders
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ML, PWOD, NURO, CARA on Behalf of Shareholders SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ML, PWOD, NURO, CARA on Behalf of Shareholders PR...
PR Newswire·11mo ago
News Placeholder
CARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick and Foti, LLC Investigates Merger of Cara Therapeutics, Inc. - CARA
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of Cara Therapeutics, Inc. (NasdaqCM: CARA) and...
Business Wire·11mo ago

Latest CARA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.